The role of amylin in the control of energy homeostasis
Open accessThe DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
Amylin is an important player in the control of nutrient fluxes. Amylin reduces eating via a meal size effect by promoting meal-ending satiation. This effect seems to depend on a direct action in the area postrema (AP), which is an area rich in amylin receptors. Subsequent to the activation of AP neurons, the neural signal is conveyed to the forebrain via relays involving the nucleus of the solitary tract (NTS) and the lateral parabrachial nucleus (lPBN) to the lateral hypothalamic area (LHA) and other hypothalamic nuclei. While the NTS and lPBN seem to be necessary for amylin's eating inhibitory effect, the role of the LHA has not yet been fully investigated. Amylin may also act as an adiposity signal. Plasma levels of amylin are higher in obese individuals, and chronic infusion of amylin into the brain reduces body weight gain and adiposity; chronic infusion of an amylin receptor antagonist into the brain increases body adiposity. Amylin increases energy expenditure in rats; this effect occurs under various experimental conditions after peripheral and central administration. Together, these animal data, but also clinical data in humans, indicate that amylin is a promising candidate for the treatment of obesity; effects are most pronounced when amylin is combined with leptin. Finally, recent findings indicate that amylin acts as a neurotrophic factor in specific brain stem areas. Whether this effect may be relevant under physiological conditions requires further studies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor
McLatchie, L. M., Fraser, N. J., Main, M. J., Wise, A., Brown, J., Thompson, N., Solari, R., Lee, M. G., & Foord, S. M. (1998) · Nature · doi:10.1038/30666 · Cited by 2,134 · cited 4×
“Further, amylin-induced c-Fos mRNA and RAMP3 mRNA expression colocalize in the rat AP (7), and amylin-sensitive AP neurons carry the CT-R (8).”
BackgroundInfluentialBarrachina, M. D., Martínez, V., Wang, L., Wei, J. Y., & Taché, Y. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.19.10455 · Cited by 440
Roth, J. D., Roland, B. L., Cole, R. L., Trevaskis, J. L., Weyer, C., Koda, J. E., Anderson, C. M., Parkes, D. G., & Baron, A. D. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0706473105 · Cited by 436 · cited 10×
“In other words, while reduced eating (perhaps by an enhanced satiation effect) is involved (14, 26, 58), it is not yet clear whether the body weight-lowering effect of chronic pharmacotherapy with pramlintide in humans is also based on higher energy expenditure, enhanced adiposity signaling (which may be mediated by o…”
BackgroundInfluentialEffect of pramlintide on satiety and food intake in obese subjects and subjects with type 2 diabetes
Chapman, I., Parker, B., Doran, S., Feinle-Bisset, C., Wishart, J., Strobel, S., Wang, Y., Burns, C., Lush, C., Weyer, C., et al. (2005) · Diabetologia · doi:10.1007/s00125-005-1732-4 · Cited by 205 · cited 2×
“In other words, while reduced eating (perhaps by an enhanced satiation effect) is involved (14, 26, 58), it is not yet clear whether the body weight-lowering effect of chronic pharmacotherapy with pramlintide in humans is also based on higher energy expenditure, enhanced adiposity signaling (which may be mediated by o…”
BackgroundSignals that influence food intake and body weight
WOODS, S. (2005) · Physiology & Behavior · doi:10.1016/j.physbeh.2005.08.060 · Cited by 131 · cited 3×
“It was already briefly mentioned that amylin shares characteristics of satiation signals, like CCK, but also of adiposity signals, like leptin or insulin (25, 62, 77, 78).”
BackgroundResultEnoki, S., Mitsukawa, T., Takemura, J., Nakazato, M., Aburaya, J., Toshimori, H., & Matsukara, S. (1992) · Diabetes Research and Clinical Practice · doi:10.1016/0168-8227(92)90074-2 · Cited by 118 · cited 1×
“Basal and glucose-stimulated plasma amylin levels are also elevated in obese humans (20, 24), and our own recent data indicate that this is also true in cats (35); lean and obese cats in that study were of similar age and body weight (4.”
BackgroundThe blood-brain barrier: connecting the gut and the brain
Banks, W. A. (2008) · Regulatory Peptides · doi:10.1016/j.regpep.2007.08.027 · Cited by 104 · cited 1×
“The suggested causes of this resistance phenomenon are numerous and seem to involve changes at the level of the blood brain barrier because transport of leptin and insulin through the blood brain barrier are reduced in obesity (3-5).”
BackgroundWeyer, C., Vozarova, B., Ravussin, E., & Tataranni, P. (2001) · International Journal of Obesity · doi:10.1038/sj.ijo.0801610 · Cited by 91 · cited 1×
“Hence, we consider the effect of amylin to prevent the compensatory decrease in energy expenditure that is typically seen in weight-reduced animals or fasted humans (73) as indicative of a physiologically relevant effect on energy balance.”
BackgroundMuff, R., Born, W., Lutz, T. A., & Fischer, J. A. (2004) · Peptides · doi:10.1016/j.peptides.2004.08.007 · Cited by 62 · cited 5×
“As discussed in Amylin Acts as a Satiation Signal, the amylin receptor consists of a heterodimer of the CT-R core receptor and RAMP1 or RAMP3 (36, 42).”
BackgroundInfluentialSelf-citation
Cited by
Sex differences in the physiology of eating
Asarian, L., & Geary, N. (2013) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00446.2012 · Cited by 513
Amylin: Pharmacology, Physiology, and Clinical Potential
Hay, D. L., Chen, S., Lutz, T. A., Parkes, D. G., & Roth, J. D. (2015) · Pharmacological Reviews · doi:10.1124/pr.115.010629 · Cited by 400
“Overall, the neuroaxis that is activated by peripheral amylin or its analogs has been reasonably well defined (Potes and Lutz, 2010).”
BackgroundInfluentialSelf-citationPeripheral Cannabinoid-1 Receptor Inverse Agonism Reduces Obesity by Reversing Leptin Resistance
Tam, J., Cinar, R., Liu, J., Godlewski, G., Wesley, D., Jourdan, T., Szanda, G., Mukhopadhyay, B., Chedester, L., Liow, J.-S., et al. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.07.002 · Cited by 356
Islet amyloid polypeptide: structure, function, and pathophysiology
Akter, R., Cao, P., Noor, H., Ridgway, Z., Tu, L.-H., Wang, H., Wong, A. G., Zhang, X., Abedini, A., Schmidt, A. M., et al. (2016) · Journal of Diabetes Research · doi:10.1155/2016/2798269 · Cited by 273
“In rats, the circulating concentration of IAPP is reported to be on the order of 3 to 5 picomolar and to rise to 15 to 20 picomolar with elevation of blood glucose [4, 5].”
BackgroundMechanisms of islet amyloidosis toxicity in type 2 diabetes
Abedini, A., & Schmidt, A. M. (2013) · FEBS Letters · doi:10.1016/j.febslet.2013.01.017 · Cited by 200
“The normal physiological roles of adaptive IAPP are not completely understood in humans, but studies in rodent models show that IAPP is involved in the suppression of satiety and adiposity, as well as the regulation of glucose homeostasis via inhibition of glucose-stimulated insulin secretion (GSIS), gastric emptying,…”
Background
Metadata
- Authors
- Lutz, T. A.
- Venue
- American Journal of Physiology-Regulatory, Integrative and Comparative Physiology
- Publisher
- American Physiological Society
- Published
- 2010-06
- Volume
- 298
- Issue
- 6
- Pages
- R1475-R1484
- ISSN
- 0363-6119 (ISSN-L)
- 1522-1490
- OpenAlex
- W1966909071
- Cited by
- 175
- References
- 9
- FWCI
- 5.31
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.